Patient Education
Share your love
2023 Recap: Top 15 Research in Ophthalmology
2024 Recap is here! Click to review:Top 10 Breakthroughs in Ophthalmology Research In the fast-evolving landscape of ophthalmology research, 2023 has proven to be a pivotal year marked by groundbreaking discoveries and innovation. From revolutionary cell replacement therapies to novel…
Top 12 Ophthalmic Drugs That Received FDA Approval
2024 Recap is here! Click to review:Top 8 FDA Approvals in Opthalmology In a series of groundbreaking developments, the FDA has approved a range of innovative drugs in 2023, heralding a new era in ophthalmic treatments. Here’s an in-depth look…
VisiRose Unveils Non-Invasive Therapy for Keratitis
VisiRose, a newly established company formed in collaboration with Provectus Biopharmaceuticals and the Bascom Palmer Eye Institute (BPEI) at the University of Miami Miller School of Medicine, is advancing the development of Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT). This…
First Inverted Meniscus Optics IOLs by Voptica
*This exclusive article is sponsored by Voptica. The opinions expressed in this article are the sponsor’s own. Intraocular lenses (IOLs) designs are constantly evolving to improve patients’ vision needs. Trifocal diffractive IOLs are designed to achieve good visual acuity at…
Yamane Technique – Intrascleral IOL Fixation
In cataract surgery, the optimal outcome involves implanting an intraocular lens (IOL) within the capsular bag. However, complications such as posterior capsule rupture, congenital lens anomalies, or traumatic injuries can leave patients without adequate capsular support, resulting in aphakia—a condition…
ESCRS 2024 Exclusive Insights: iNovation Day in Focus
The European Society of Cataract and Refractive Surgeons (ESCRS) is gearing up for an innovative event with its iNovation® Day in Barcelona, Spain, on Friday 6 September 2024 at the Fira Barcelona Gran Via. Scheduled to be held prior to…
Stem Cell Breakthrough Restores Vision in LSCD Patients
In a groundbreaking achievement, researchers from Osaka University in Japan have successfully conducted the first human trial using induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency (LSCD). This innovative approach marks a significant advancement in vision restoration…
Bimekizumab Reduces Uveitis Incidence in axSpA Patients
The study led by Matthew A. Brown, Genomics England, London, United Kingdom, and Martin Rudwaleit, Klinikum Bielefeld, University of Bielefeld, Bielefeld, Germany. Patients with axial spondyloarthritis (axSpA) treated with bimekizumab exhibited a markedly lower incidence of uveitis compared to those receiving…
U.S. Glaucoma Prevalence and Risk Factors Study
A new study titled “Prevalence of Glaucoma Among US Adults in 2022”, published in JAMA Ophthalmology, has revealed updated statistics on the prevalence of glaucoma in the United States. The research shows that approximately 4.22 million U.S. adults (1.62% of…
Rethinking Dry Eye Diagnosis in Resistant Patients
Many conditions can mimic dry eye disease (DED), leading to misdiagnoses and ineffective treatments, warned Vatinee Y. Bunya, MD, MSCE, during a presentation at Cornea Subspecialty Day at the American Academy of Ophthalmology meeting. Dr. Bunya emphasized the need for…